杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/30 | 1,757 | 1,758 | 1,740 | 1,751 | -5 | -0.3% | 85,500 |
| 2023/06/29 | 1,766 | 1,775 | 1,751 | 1,756 | -11 | -0.6% | 68,800 |
| 2023/06/28 | 1,748 | 1,767 | 1,746 | 1,767 | +19 | +1.1% | 80,900 |
| 2023/06/27 | 1,758 | 1,760 | 1,735 | 1,748 | -20 | -1.1% | 76,900 |
| 2023/06/26 | 1,780 | 1,781 | 1,756 | 1,768 | -5 | -0.3% | 80,200 |
| 2023/06/23 | 1,788 | 1,788 | 1,767 | 1,773 | -11 | -0.6% | 119,700 |
| 2023/06/22 | 1,768 | 1,787 | 1,768 | 1,784 | +16 | +0.9% | 92,600 |
| 2023/06/21 | 1,772 | 1,786 | 1,766 | 1,768 | +4 | +0.2% | 124,000 |
| 2023/06/20 | 1,757 | 1,764 | 1,748 | 1,764 | ±0 | ±0% | 45,400 |
| 2023/06/19 | 1,759 | 1,771 | 1,752 | 1,764 | +7 | +0.4% | 57,400 |
| 2023/06/16 | 1,738 | 1,759 | 1,737 | 1,757 | +16 | +0.9% | 202,700 |
| 2023/06/15 | 1,734 | 1,748 | 1,733 | 1,741 | +3 | +0.2% | 83,200 |
| 2023/06/14 | 1,748 | 1,748 | 1,733 | 1,738 | -8 | -0.5% | 81,900 |
| 2023/06/13 | 1,750 | 1,759 | 1,741 | 1,746 | ±0 | ±0% | 99,200 |
| 2023/06/12 | 1,748 | 1,753 | 1,735 | 1,746 | +7 | +0.4% | 86,600 |
| 2023/06/09 | 1,751 | 1,751 | 1,733 | 1,739 | +2 | +0.1% | 139,300 |
| 2023/06/08 | 1,735 | 1,744 | 1,725 | 1,737 | +10 | +0.6% | 97,300 |
| 2023/06/07 | 1,741 | 1,753 | 1,723 | 1,727 | -19 | -1.1% | 113,500 |
| 2023/06/06 | 1,733 | 1,746 | 1,717 | 1,746 | +9 | +0.5% | 115,400 |
| 2023/06/05 | 1,733 | 1,758 | 1,725 | 1,737 | -36 | -2% | 207,600 |
| 2023/06/02 | 1,749 | 1,773 | 1,747 | 1,773 | +30 | +1.7% | 91,800 |
| 2023/06/01 | 1,750 | 1,762 | 1,740 | 1,743 | +12 | +0.7% | 104,000 |
| 2023/05/31 | 1,751 | 1,760 | 1,718 | 1,731 | -33 | -1.9% | 376,300 |
| 2023/05/30 | 1,782 | 1,782 | 1,756 | 1,764 | -22 | -1.2% | 60,700 |
| 2023/05/29 | 1,780 | 1,799 | 1,769 | 1,786 | +27 | +1.5% | 82,300 |
| 2023/05/26 | 1,793 | 1,793 | 1,758 | 1,759 | -36 | -2% | 72,100 |
| 2023/05/25 | 1,786 | 1,808 | 1,781 | 1,795 | +9 | +0.5% | 127,300 |
| 2023/05/24 | 1,795 | 1,796 | 1,782 | 1,786 | -4 | -0.2% | 104,100 |
| 2023/05/23 | 1,784 | 1,794 | 1,779 | 1,790 | +14 | +0.8% | 177,900 |
| 2023/05/22 | 1,747 | 1,778 | 1,746 | 1,776 | +35 | +2% | 66,800 |
| 2023/05/19 | 1,755 | 1,755 | 1,735 | 1,741 | -4 | -0.2% | 66,300 |
| 2023/05/18 | 1,770 | 1,770 | 1,742 | 1,745 | -17 | -1% | 64,300 |
| 2023/05/17 | 1,763 | 1,769 | 1,756 | 1,762 | -4 | -0.2% | 57,800 |
| 2023/05/16 | 1,750 | 1,766 | 1,745 | 1,766 | +22 | +1.3% | 89,400 |
| 2023/05/15 | 1,740 | 1,749 | 1,737 | 1,744 | +11 | +0.6% | 64,100 |
| 2023/05/12 | 1,730 | 1,740 | 1,723 | 1,733 | +13 | +0.8% | 88,100 |
| 2023/05/11 | 1,732 | 1,733 | 1,718 | 1,720 | -22 | -1.3% | 46,300 |
| 2023/05/10 | 1,753 | 1,753 | 1,739 | 1,742 | -14 | -0.8% | 56,000 |
| 2023/05/09 | 1,759 | 1,759 | 1,752 | 1,756 | +7 | +0.4% | 50,800 |
| 2023/05/08 | 1,741 | 1,761 | 1,741 | 1,749 | +10 | +0.6% | 58,500 |
| 2023/05/02 | 1,760 | 1,763 | 1,733 | 1,739 | -16 | -0.9% | 65,600 |
| 2023/05/01 | 1,755 | 1,761 | 1,748 | 1,755 | +8 | +0.5% | 64,000 |
| 2023/04/28 | 1,748 | 1,752 | 1,740 | 1,747 | +21 | +1.2% | 77,400 |
| 2023/04/27 | 1,724 | 1,732 | 1,718 | 1,726 | +2 | +0.1% | 56,800 |
| 2023/04/26 | 1,738 | 1,738 | 1,720 | 1,724 | -17 | -1% | 46,500 |
| 2023/04/25 | 1,733 | 1,748 | 1,733 | 1,741 | +15 | +0.9% | 94,000 |
| 2023/04/24 | 1,723 | 1,735 | 1,718 | 1,726 | +3 | +0.2% | 110,600 |
| 2023/04/21 | 1,729 | 1,733 | 1,722 | 1,723 | -8 | -0.5% | 53,100 |
| 2023/04/20 | 1,722 | 1,735 | 1,722 | 1,731 | +2 | +0.1% | 57,400 |
| 2023/04/19 | 1,735 | 1,735 | 1,724 | 1,729 | -11 | -0.6% | 43,400 |
451～
500
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 147,000円 | +8.8% | +99.9% | 3.54% | 9.38倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ジーエヌアイ | 231,800円 | +21.7% | +999.9% | 0.00% | 9.65倍 | 3.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 307,000円 | +3.0% | +27.5% | 2.61% | 19.44倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 221,000円 | +0.4% | -8.4% | 2.40% | 28.37倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 90,100円 | +20.3% | - | 0.00% | 158.91倍 | 1.18倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
